European Summit on the Prevention and Self-Management of Chronic Respiratory Diseases: report of the European Union Parliament Summit (29 March 2017)

Abstract On March 29, 2017, a European Summit on the Prevention and Self-Management of Chronic Respiratory Diseases (CRD) was organized by the European Forum for Research and Education in Allergy and Airway Diseases. The event took place in the European Parliament of Brussels and was hosted by MEP David Borrelli and MEP Sirpa Pietikainen. The aim of the Summit was to correspond to the needs of the European Commission and of patients suffering from CRD to join forces in Europe for the prevention and self-management. Delegates of the European Rhinologic Society, European Respiratory Society, European Academy of Allergy and Clinical Immunology, European Academy of Paediatrics, and European Patients Organization EFA all lectured on their vision and action plan to join forces in achieving adequate prevention and self-management of CRD in the context of Precision Medicine. Recent data highlight the preventive capacity of education on optimal care pathways for CRD. Self-management and patient empowerment can be achieved by novel educational on-line materials and by novel mobile health tools enabling patients and doctors to monitor and optimally treat CRDs based on the level of control. This report summarizes the contributions of the representatives of different European academic stakeholders in the field of CRD.

[1]  J. Bousquet,et al.  Allergic Rhinitis and its Impact on Asthma (ARIA) , 2003 .

[2]  V. Lund,et al.  Health‐Related Quality of Life after Polypectomy with and without Additional Surgery , 2006, The Laryngoscope.

[3]  J Bousquet,et al.  Global Alliance against Chronic Respiratory Diseases , 2007, European Respiratory Journal.

[4]  G. Viegi,et al.  Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 * , 2008, Allergy.

[5]  T. Haahtela,et al.  Finnish Allergy Programme 2008–2018 – time to act and change the course , 2008, Allergy.

[6]  E. Vartiainen,et al.  Scientific rationale for the Finnish Allergy Programme 2008–2018: emphasis on prevention and endorsing tolerance , 2009, Allergy.

[7]  D. Blumenthal.  Stimulating the adoption of health information technology. , 2009, The West Virginia medical journal.

[8]  M. Rottem.  [Allergic rhinitis and its impact on asthma]. , 2010, Harefuah.

[9]  J. Bousquet,et al.  Validation of a questionnaire (CARAT10) to assess rhinitis and asthma in patients with asthma , 2010, Allergy.

[10]  J Bousquet,et al.  Chronic rhinosinusitis in Europe – an underestimated disease. A GA2LEN study , 2011, Allergy.

[11]  J. Bousquet,et al.  Council of the European Union conclusions on chronic respiratory diseases in children , 2012, The Lancet.

[12]  C. Akdis,et al.  Defective epithelial barrier in chronic rhinosinusitis: the regulation of tight junctions by IFN-γ and IL-4. , 2012, The Journal of allergy and clinical immunology.

[13]  V. Hox,et al.  Negative impact of occupational exposure on surgical outcome in patients with rhinosinusitis , 2012, Allergy.

[14]  D. Jarvis,et al.  Asthma in adults and its association with chronic rhinosinusitis: The GA2LEN survey in Europe , 2012, Allergy.

[15]  Yu-zhi Chen,et al.  [Allergic Rhinitis and its Impact on Asthma (ARIA) achievements in 10 years and future needs]. , 2012, Zhonghua er bi yan hou tou jing wai ke za zhi = Chinese journal of otorhinolaryngology head and neck surgery.

[16]  J. Bousquet,et al.  Prevention and control of childhood asthma and allergy in the EU from the public health point of view: Polish Presidency of the European Union , 2012, Allergy.

[17]  J. Bousquet,et al.  Impact of early diagnosis and control of chronic respiratory diseases on active and healthy ageing , 2013, Allergy.

[18]  J. Bousquet,et al.  Uncontrolled allergic rhinitis and chronic rhinosinusitis: where do we stand today? , 2013, Allergy.

[19]  W. Fokkens,et al.  Occupational upper airway disease: how work affects the nose , 2014, Allergy.

[20]  G. Brusselle,et al.  Early origins of chronic obstructive lung diseases across the life course , 2014, European Journal of Epidemiology.

[21]  D. Postma,et al.  Transient early wheeze and lung function in early childhood associated with chronic obstructive pulmonary disease genes. , 2014, The Journal of allergy and clinical immunology.

[22]  C. Auffray,et al.  Systems medicine approaches for the definition of complex phenotypes in chronic diseases and ageing. From concept to implementation and policies. , 2014, Current pharmaceutical design.

[23]  J. Bousquet,et al.  Allergen Immunotherapy (AIT): a prototype of Precision Medicine , 2015, The World Allergy Organization journal.

[24]  V. Lund,et al.  Does time to endoscopic sinus surgery impact outcomes in Chronic Rhinosinusitis? Prospective findings from the National Comparative Audit of Surgery for Nasal Polyposis and Chronic Rhinosinusitis. , 2015, Rhinology.

[25]  D. Postma,et al.  Developmental determinants in non-communicable chronic diseases and ageing , 2015, Thorax.

[26]  F. Rodenas,et al.  MACVIA‐ARIA Sentinel NetworK for allergic rhinitis (MASK‐rhinitis): the new generation guideline implementation , 2015, Allergy.

[27]  Ioana Agache,et al.  Global Atlas of Allergic Rhinitis and Chronic Rhinosinusitis , 2015 .

[28]  Does time to endoscopic sinus surgery impact outcomes in Chronic Rhinosinusitis? Prospective findings from the National Comparative Audit of Surgery for Nasal Polyposis and Chronic Rhinosinusitis. , 2015 .

[29]  Europe needs to protect children and youths against secondhand smoke , 2016, European Journal of Pediatrics.

[30]  J. Bousquet,et al.  AIRWAYS-ICPs (European Innovation Partnership on Active and Healthy Ageing) from concept to implementation , 2016, European Respiratory Journal.

[31]  Todor A Popov,et al.  ARIA 2016: Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle , 2016, Clinical and Translational Allergy.

[32]  J. Bousquet,et al.  European Symposium on Precision Medicine in Allergy and Airways Diseases: Report of the European Union Parliament Symposium (October 14, 2015) , 2015, Allergy.

[33]  D. Postma,et al.  Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5) , 2016, Clinical and Translational Allergy.

[34]  Rosalind Stanwell-Smith,et al.  Time to abandon the hygiene hypothesis: new perspectives on allergic disease, the human microbiome, infectious disease prevention and the role of targeted hygiene , 2016, Perspectives in public health.

[35]  S. Galli,et al.  Toward precision medicine and health: Opportunities and challenges in allergic diseases. , 2016, The Journal of allergy and clinical immunology.

[36]  T. Casale,et al.  Precision medicine in patients with allergic diseases: Airway diseases and atopic dermatitis-PRACTALL document of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma & Immunology. , 2016, The Journal of allergy and clinical immunology.

[37]  I. Agache,et al.  Endotypes of allergic diseases and asthma: An important step in building blocks for the future of precision medicine. , 2016, Allergology international : official journal of the Japanese Society of Allergology.

[38]  P. Hellings,et al.  Impaired barrier function in patients with house dust mite-induced allergic rhinitis is accompanied by decreased occludin and zonula occludens-1 expression. , 2016, The Journal of allergy and clinical immunology.

[39]  J. Bousquet,et al.  EUFOREA Rhinology Research Forum 2016: report of the brainstorming sessions on needs and priorities in rhinitis and rhinosinusitis. , 2017, Rhinology.

[40]  A. Magnan,et al.  Personalised medicine in asthma: from curative to preventive medicine , 2017, European Respiratory Review.

[41]  D. Ryan,et al.  Positioning the principles of precision medicine in care pathways for allergic rhinitis and chronic rhinosinusitis – A EUFOREA‐ARIA‐EPOS‐AIRWAYS ICP statement , 2017, Allergy.

[42]  T. Haahtela,et al.  The Finnish experience to save asthma costs by improving care in 1987‐2013 , 2017, The Journal of allergy and clinical immunology.

[43]  L. Vangerven,et al.  report of the brainstorming sessions on needs and priorities in rhinitis and rhinosinusitis , 2017 .

[44]  J. Bousquet,et al.  The Finnish Allergy Programme 2008–2018 works , 2017, European Respiratory Journal.